
Rahul Mehta, PhD
Co-Founder & CEO, Rapalogix / Re-Q Health
Skin longevity at the cellular level.
Conversations shaping the future of aesthetics and wellness.
Hosted by Taylor Semien, NP
LATEST EPISODE / EP. 01 · PART 2
Doris Day, MD, FAAD · New York dermatologist, co-founder of Rapalogix / Re-Q Health
Doris Day, MD, FAADNew York dermatologist, co-founder of Rapalogix / Re-Q Health
Hosted by Taylor Semien, NP
· 28:10
Why do the treatments that worked in your 30s stop working in your 40s, 50s and 60s? Two clinicians compare notes on the fibroblast — the cell that builds collagen and elastin — the mTORC1 pathway, prepping skin for laser, layering Re-Q with retinoids, perimenopause and menopause, and what an aesthetic consult may look like in five years.
Dr. Doris Day is a co-founder of Rapalogix, maker of Re-Q. This content is educational and is not medical advice. Talk with a licensed provider about whether any treatment is right for you.
Coming soon

Co-Founder & CEO, Rapalogix / Re-Q Health
Skin longevity at the cellular level.
Re-Q Health PR · voice of the under-30 men's skincare and wellness market
The male market in aesthetics, wellness and longevity.